What they were paid
Trevi Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $65,000 | $0 | $218,430 | $0 | $283,430 |
| FY2024 | $65,000 | — | $68,246 | — | $133,246 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Trevi Therapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166695, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Trevi Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair)
The rest of the Trevi Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Anne VanLent | Independent Director | $283,430 |
| David Meeker, M.D | Independent Director | $293,430 |
| Dominick Colangelo | Independent Director | $275,930 |
| Edward Mathers | Independent Director | $265,930 |
| Jennifer Good | Director | $0 |
The full Trevi Therapeutics compensation record
free company briefThis page is one director within Trevi Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat